Editorial: Ex-vivo and in-vivo genome engineering for metabolic and neurometabolic diseases
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-07-01
|
Series: | Frontiers in Genome Editing |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fgeed.2023.1248904/full |
_version_ | 1797785616651386880 |
---|---|
author | Pasqualina Colella Vasco Meneghini Vasco Meneghini Guilherme Baldo Natalia Gomez-Ospina |
author_facet | Pasqualina Colella Vasco Meneghini Vasco Meneghini Guilherme Baldo Natalia Gomez-Ospina |
author_sort | Pasqualina Colella |
collection | DOAJ |
first_indexed | 2024-03-13T00:57:35Z |
format | Article |
id | doaj.art-e86efa01aac249639a95a8183942dc2a |
institution | Directory Open Access Journal |
issn | 2673-3439 |
language | English |
last_indexed | 2024-03-13T00:57:35Z |
publishDate | 2023-07-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Genome Editing |
spelling | doaj.art-e86efa01aac249639a95a8183942dc2a2023-07-06T18:45:59ZengFrontiers Media S.A.Frontiers in Genome Editing2673-34392023-07-01510.3389/fgeed.2023.12489041248904Editorial: Ex-vivo and in-vivo genome engineering for metabolic and neurometabolic diseasesPasqualina Colella0Vasco Meneghini1Vasco Meneghini2Guilherme Baldo3Natalia Gomez-Ospina4Department of Pediatrics, Stanford University, Stanford, CA, United StatesSan Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, Milan, ItalyVita-Salute San Raffaele University, Milan, ItalyClinical Hospital of Porto Alegre, Federal University of Rio Grande do Sul, Porto Alegre, BrazilDepartment of Pediatrics, Stanford University, Stanford, CA, United Stateshttps://www.frontiersin.org/articles/10.3389/fgeed.2023.1248904/fullgenome editingneurometabolicliverretinaHSPCmetabolic |
spellingShingle | Pasqualina Colella Vasco Meneghini Vasco Meneghini Guilherme Baldo Natalia Gomez-Ospina Editorial: Ex-vivo and in-vivo genome engineering for metabolic and neurometabolic diseases Frontiers in Genome Editing genome editing neurometabolic liver retina HSPC metabolic |
title | Editorial: Ex-vivo and in-vivo genome engineering for metabolic and neurometabolic diseases |
title_full | Editorial: Ex-vivo and in-vivo genome engineering for metabolic and neurometabolic diseases |
title_fullStr | Editorial: Ex-vivo and in-vivo genome engineering for metabolic and neurometabolic diseases |
title_full_unstemmed | Editorial: Ex-vivo and in-vivo genome engineering for metabolic and neurometabolic diseases |
title_short | Editorial: Ex-vivo and in-vivo genome engineering for metabolic and neurometabolic diseases |
title_sort | editorial ex vivo and in vivo genome engineering for metabolic and neurometabolic diseases |
topic | genome editing neurometabolic liver retina HSPC metabolic |
url | https://www.frontiersin.org/articles/10.3389/fgeed.2023.1248904/full |
work_keys_str_mv | AT pasqualinacolella editorialexvivoandinvivogenomeengineeringformetabolicandneurometabolicdiseases AT vascomeneghini editorialexvivoandinvivogenomeengineeringformetabolicandneurometabolicdiseases AT vascomeneghini editorialexvivoandinvivogenomeengineeringformetabolicandneurometabolicdiseases AT guilhermebaldo editorialexvivoandinvivogenomeengineeringformetabolicandneurometabolicdiseases AT nataliagomezospina editorialexvivoandinvivogenomeengineeringformetabolicandneurometabolicdiseases |